Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Perseus Biomics logo — Delivering more precise microbiome profiles, faster

Perseus Biomics

Delivering more precise microbiome profiles, faster

Founded 2020 Belgium Belgium 19 employees Grant Total: $2.50M Biotechnology, Health Care

General Information

Company Name Perseus Biomics
Founded Year 2020
Location Belgium Belgium
Employees 19
Industries Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Perseus Biomics. To contact Perseus Biomics, visit perseusbiomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Perseus Biomics compare?

A PDF of Perseus Biomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Perseus Biomics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Perseus Biomics

Perseus Biomics is a Biotechnology, Health Care startup based in Belgium, dedicated to delivering more precise microbiome profiles at a faster pace. Founded in 2018, the company is driven by its slogan of 'Delivering more precise microbiome profiles, faster.' Perseus Biomics offers a unique solution through its DynaMAP technology, which empowers microbiome research, therapeutics, and personalized medicine with the ultimate aim of improving health. Recently, the company received a significant €2.50M grant investment on 16 June 2021 from the European Innovation Council. This investment is a clear indication of the confidence and support Perseus Biomics has garnered from prominent backers. The opportunity to combine state-of-the-art technology with the advancement of healthcare underscores the potential of Perseus Biomics as a strong contender in the biotech industry. Perseus Biomics' innovative approach has the potential to make a profound impact on microbiome analysis, offering researchers and clinicians the ability to perform precise, reproducible, and resource-efficient microbiome analysis both in laboratories and at point-of-need. Their commitment to leveraging technology for the betterment of health positions them as a compelling prospect worthy of attention within the startup and investment landscape.

Business keywords: microbiome analysis, DynaMAP technology, microbiome research, therapeutics, personalized medicine, health improvement

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
European Innovation Council
European Innovation Council
16 Jun 2021
Grant €2.50M 1
European Innovation Council
European Innovation Council
16 Jun 2021

Perseus Biomics Alternatives & Competitors

View All Alternatives
Perseus Biomics vs
MRM Health
MRM Health Belgium

Redefining microbiome-based therapeutics

Grant
45 employees
Biotechnology, Health Care
Compare Perseus Biomics vs MRM Health
Perseus Biomics vs
BiomeSense
BiomeSense United States

Developing novel tools to enable the routine, low-cost analysis of human microbiome data.

Venture round
15 employees
Analytics, Biotechnology
Perseus Biomics vs
DayTwo
DayTwo United States

Precision Nutrition for Metabolic Disease

16 employees
Biotechnology, Health Care
View all alternatives

FAQ About Perseus Biomics

Delivering more precise microbiome profiles, faster
Perseus Biomics was founded in 2020.
Perseus Biomics is headquartered in Belgium.
Perseus Biomics operates in Biotechnology and Health Care. Its work centres on microbiome analysis, DynaMAP technology, microbiome research and therapeutics.
Perseus Biomics has approximately 19 employees.
Perseus Biomics has completed 2 funding rounds, raising a total of $2.50M. The latest funding stage is Grant.
Top alternatives and competitors to Perseus Biomics include MRM Health, BiomeSense, DayTwo, GMT Science, Epividian, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Perseus Biomics and MRM Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Perseus Biomics, https://bouncewatch.com/company/perseus-biomics, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes